Insight Partners and Tiger Global Management co-led a series C round valuing the Google, Slack and Intel-backed collaboration software provider above $2bn.

6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.

Telefónica-backed addiction treatment app developer Quit Genius raised $64m while oral care product maker NYSCPS received almost as much in a round featuring ByteDance.

Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.

Kaiser Permanente co-led the medical data software provider's latest round, pushing its total funding past the $170m mark.

Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.

Target Global led the RGA-backed gamified life insurance platform’s series B round, which valued it at almost $350m.

The BCC and SIG-backed news aggregator was valued at about $550m in a round led by technology investment firm Vy Capital.

Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.

Bank Central Asia’s Central Capital Ventura unit and Cohen and Company were among the investors in the banking software provider’s latest round.